Top

Published in:

01-06-2009 | Original Article

Association of various inflammatory diseases with human leukocyte antigens B27, B7, Bw4 and Bw6 in patients with SSA

Authors: Sangeeta Singh, Gyanendra K. Sonkar, Usha Singh

Published in: Rheumatology International | Issue 9/2009

Abstract

Seronegative spondyloarthropathies (SSA) are a group of inflammatory disorders, which clinically involve the axial skeleton and the sacroiliiac and shoulder joints. The aim of the present study was to study the association of HLA B27, B7, Bw4 and Bw6 with some inflammatory diseases, in SSA patients in our area. A total of 220 SSA patients were studied and HLA typing for these antigens were done by the complement-mediated microcytotoxicity method. The total positivity of B27 was found to be 68.64% in SSA patients. Tubercular infection (χ² = 8.06) and acute anterior uveitis (χ² = 6.19) were found to be statistically significant (P < 0.05) in B27-positive SSA patients. Tuberculosis was also found to be significantly (χ² = 6.40) associated with Bw4. In SSA urinary tract infection, gastrointestinal infection and streptococcal infection were not significantly associated with B27, B7, Bw4 or Bw6 antigens. Our study concludes that microbial infections do have some pathogenic role in causing SSA.

Dhurandhar PS, Shankarkumar U (2007) HLA association in seronegative spondyloarthritis patients from Mumbai, India. Int J Hum Genet 7:235–239

Brewerton DA, Caffrey MFP, Hart FD, James DCO, Nichols A, Sturrock RD (1973) Ankylosing spondylitis and HLA-B27. Lancet 1:904–907. doi:10.1016/S0140-6736(73)91360-3 PubMedCrossRef

Khan MA (1988) Genetics of HLA-B27. Br J Rheumatol 27:6–11PubMed

Bjorkman PJ, Saper MA, Samraoui B, Bennett WS, Strominger JL, Wiley DC (1987) Structure of human class I histocompatibility antigen, HLA-A2. Nature 329:506–512. doi:10.1038/329506a0 PubMedCrossRef

Benjamin R, Parham P (1990) Guilt by association: HLA-B27 and ankylosing spondylitis. Immunol Today 11:137–142. doi:10.1016/0167-5699(90)90051-A PubMedCrossRef

Egringer A, Cowling P, Ngwa Suh et al (1976) Cross-reactivity between Klebsiela aerogenes species and HLA-B27 lymphocyte antigen as an aetiological factor in ankylosing spondylitis. In: Dausset J, Svejgaad A (eds) HLA and disease. Paris, INSERM, p 27

Theofilopoulos AN (1995) The basis of autoimmunity: Part 1. Mechanisms of aberrant self-recognition. Immunol Today 16:90–98. doi:10.1016/0167-5699(95)80095-6 PubMedCrossRef

Murray CJ, Styblo K, Rouillon A (1990) Tuberculosis in developing countries: burden, intervention and cost. Bull Int Union Tuberc Lung Dis 65:6–24PubMed

Hafez M, el-Salab S, el-Shennawy F, Bassiony MR (1985) HLA-antigens and tuberculosis in the Egyptian population. Tubercle 66:35–40. doi:10.1016/0041-3879(85)90051-0 PubMedCrossRef

10.

Zervas J, Constantopoulos C, Toubis M, Anagnostopoulos D, Costovoulou V (1998) HLA-A and B antigens and pulmonary tuberculosis in Greeks. Br J Dis Chest 81:147–149. doi:10.1016/0007-0971(87)90132-X CrossRef

11.

Hawkin BR, Higgins DA, Chan SL, Lowrie DB, Mitchison DA, Girling DJ (1988) HLA typing in the Hong Kong Chest Service/British Medical Research Council study of factors associated with the breakdown to active tuberculosis of inactive pulmonary lesions. Am Rev Respir Dis 138:1616–1621

12.

Ali A, Samson CM (2007) Seronegative spondyloarthropathies and the eye. Curr Opin Ophthalmol 18:476–480. doi:10.1097/ICU.0b013e3282f0fda2 PubMedCrossRef

13.

Hannu T, Puolakkainen M, Leirisalo-Repo M (1999) Chyamydia pneumaoniae as a triggering infection in reactive arthritis. Rheumatology 38:411–414. doi:10.1093/rheumatology/38.5.411 PubMedCrossRef

14.

Sieper J (2004) Disease mechanisms in reactive arthritis. Curr Rheumatol Rep 6:110–116. doi:10.1007/s11926-004-0055-7 PubMedCrossRef

15.

Valtonen VV, Leirisalo M, Pentikainen PJ et al (1985) Triggering infections in reactive arthritis. Ann Rheum Dis 44:399–405PubMedCrossRef

16.

Dougados M, van der Linden S, Juhlin R et al (1991) The European Spondyloarthropathy Study Group preliminary criteria for the classification of spondyloarthropathy. Arthritis Rheum 34:1218–1227. doi:10.1002/art.1780341003 PubMedCrossRef

17.

Terasaki PI, McClelland JD (1964) Microdroplet assay of human serum cytotoxins. Nature 204:998–1000PubMedCrossRef

18.

Mehra NK (1989) Basic methods in HLA-DNA technology. Technical manual published during the DBT-sponsored training workshop on HLA-DNA technology, Sagar publishers, New Delhi

19.

Selvaraj P (2004) Host genetics and tuberculosis susceptibility. Curr Sci 86:115–121

20.

Huang F, Wang L, Zhang J, Deng X, Guo J, Zhang Y (2006) Risk of tuberculosis in a Chinese registry of rheumatoid arthritis and ankylosing spondylitis for tumour necrosis-α antagonists. APLAR J Rheumatol 9:170–174. doi:10.1111/j.1479-8077.2006.00193.x CrossRef

21.

Gupta SS, Jain IS, Jain GC, Deodhar SD (1978) HLA antigens in acute anterior uveitis in North Indians. Indian J Ophthalmol 26:26–29

22.

van der Heijden IM, Wilbrink B, Schouls LM, van Embden JDA, Breedveld FC, Tak PP (1999) Detection of mycobacteria in joint samples from patients with arthritis using a genus-specific polymerase chain reaction and sequence analysis. Rheumatology 38:547–553. doi:10.1093/rheumatology/38.6.547 PubMedCrossRef

23.

Gogia A, Kakar A, Gupta PS (2007) Skeletan tuberculosis mimicking seronegative spondyloarthropathy. J Assoc Physicians India 55:740–741PubMed

24.

Linssen A, Meenken C (1995) Outcomes of HLA B27-positive and HLA B27-negative acute anterior uveitis. Am J Ophthalmol 120:351–361PubMed

25.

Monnet D, Breban M, Hudry C, Dougados M, Brezin AP (2004) Ophthalmic findings and frequency of extraocular manifestations in patients with HLA B27 uveitis: a study of 175 cases. Ophthalmology 111:802–809. doi:10.1016/j.ophtha.2003.07.011 PubMedCrossRef

26.

Zochling J, Bohl-Buhler MHJ, Baraliakos X, Feldtkeller E, Braun J (2006) Infection and work stress are potential triggers of ankylosing spondylitis. Clin Rheumatol 25:660–666. doi:10.1007/s10067-005-0131-z PubMedCrossRef

Title: Association of various inflammatory diseases with human leukocyte antigens B27, B7, Bw4 and Bw6 in patients with SSA
Authors: Sangeeta Singh
Gyanendra K. Sonkar
Usha Singh
Publication date: 01-06-2009
Publisher: Springer-Verlag
Published in: Rheumatology International / Issue 9/2009
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI: https://doi.org/10.1007/s00296-009-0902-y

ACC 2024 Congress Coverage

Heart Failure Video

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Association of various inflammatory diseases with human leukocyte antigens B27, B7, Bw4 and Bw6 in patients with SSA

Abstract

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 9/2009

A case of Poncet’s disease (tuberculous rheumatism)

Lupus nephritis among 624 cases of systemic lupus erythematosus in Riyadh, Saudi Arabia

Acute rheumatic fever in adults: case report together with an analysis of 25 patients with acute rheumatic fever

Dermatomyositis, complicated with pneumomediastinum, successfully treated with cyclosporine A: a case report and review of literature

Mycobacterium tuberculosis infection precipitates SLE in patients from endemic areas

Atypical Kawasaki disease with remarkable paucity of signs and symptoms

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page